# Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis

> **NCT05064605** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Respiratory Disease
- Chronic Pulmonary Aspergillosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05064605
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064605, "Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05064605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*